PHRX Financials 07/16/2014 13:55:38
Pharmagen, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Jun 30, 2011
Total Revenue 4,813 4,261 863 -
Cost of Revenue 1,768 2,996 454 -
Gross Profit 3,045 1,265 409 -
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 5,204 3,361 692 69
Non-Recurring Items 1,196 - - -
Other - - - -
Operating Income (3,612) (2,096) (283) (69)
Income From Continuing Operations
Add'l Income/Expense Items 362 90 - 1
Earnings Before Interest and Tax (2,993) (2,006) (283) (69)
Interest Expense 3,008 765 14 5
Earnings Before Tax (6,001) (2,771) (297) (74)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (6,001) (2,771) (297) (73)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (6,001) (2,771) (297) (74)
Preferred Stock and Other Adjustments (457) - - -
Net Income Applicable to Common Shareholders (6,458) (2,771) (297) (74)